VA106483

DRUG6 trials

Sponsors

Vantia Ltd

Conditions

Benign Prostatic Hypertrophy (BPH)Nocturia

Phase 1

Efficacy and Safety of VA106483 in Elderly Males

CompletedNCT00879138

Vantia LtdNocturia

Start: 2008-08-31End: 2009-03-31Updated: 2018-10-31

VA106483 and Alpha Blocker Interaction Study in Elderly Males

CompletedNCT00879216

Vantia LtdNocturia

Start: 2009-04-30End: 2009-07-31Updated: 2009-11-25

VA106483 Dose Response Study in Elderly Males

CompletedNCT00922740

Vantia LtdNocturia

Start: 2009-06-30End: 2009-09-30Updated: 2018-05-23

VA106483 Dose Response in Females

CompletedNCT01171391

Vantia LtdNocturia

Start: 2010-07-31End: 2010-11-30Updated: 2010-12-01

Dose Response Study of VA106483 in Males With Nocturia and Benign Prostatic Hypertrophy (BPH)

CompletedNCT01330927

Vantia LtdBenign Prostatic Hypertrophy (BPH), Nocturia

Start: 2011-03-31End: 2011-07-31Updated: 2011-08-02

Phase 2

Efficacy Study of VA106483 in Males With Nocturia.

CompletedNCT01038843

Vantia LtdNocturia

Start: 2009-12-31End: 2010-08-31Updated: 2014-06-20